Pharmacoepidemiological considerations in observed‐to‐expected analyses for vaccines
Open Access
- 25 November 2015
- journal article
- review article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 25 (2), 215-222
- https://doi.org/10.1002/pds.3918
Abstract
No abstract availableKeywords
Funding Information
- GlaxoSmithKline Biologicals SA
This publication has 20 references indexed in Scilit:
- Use of logistic regression to combine two causality criteria for signal detection in vaccine spontaneous report data.Drug Safety, 2014
- Improved Statistical Signal Detection in Pharmacovigilance by Combining Multiple Strength-of-Evidence Aspects in vigiRankDrug Safety, 2014
- Bivalent human papillomavirus vaccine and the risk of fatigue syndromes in girls in the UKVaccine, 2013
- Using time‐to‐onset for detecting safety signals in spontaneous reports of adverse events following immunization: a proof of concept studyPharmacoepidemiology and Drug Safety, 2012
- H1N1 vaccine safety: real-time surveillance in the UKThe Lancet, 2010
- Temporal pattern discovery in longitudinal electronic patient recordsData Mining and Knowledge Discovery, 2009
- Textbook of PharmacoepidemiologyPublished by Wiley ,2006
- A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactionsPharmacoepidemiology and Drug Safety, 2002
- Bayesian Data Mining in Large Frequency Tables, with an Application to the FDA Spontaneous Reporting SystemThe American Statistician, 1999
- A Bayesian neural network method for adverse drug reaction signal generationEuropean Journal of Clinical Pharmacology, 1998